AdvaMed and BioOhio to Discuss MedTech Impact on Ohio's Economy, Job Creation
/FROM PR NEWSWIRE DALLAS 888-776-3971/ [STK] [IN] HEA MTC MEQ [SU] MAV STP TO HEALTH, MEDICAL, AND STATE EDITORS: AdvaMed and BioOhio to Discuss MedTech Impact on Ohio's Economy, Job Creation Columbus (May 7, 2012) - Medical technology companies - in Ohio and across the country - are world leaders in the development of new medical devices, diagnostics and essential equipment for patients worldwide, but that leadership is at risk.
In Ohio alone, medical technology manufacturers employ more than 35,300 people, paying an average annual wage of $42,689. To preserve and protect those jobs and the life-changing innovations created locally, AdvaMed and its member companies have developed a comprehensive "Competitiveness Agenda." The agenda focuses on innovation, regulatory, reimbursement, tax and trade policies to drive the U.S. medical technology industry's future growth and success.
Please join us for this event to learn more about the Competitiveness Agenda and the impact the medical technology industry and the device tax has on the U.S. and Ohio economies.
WHAT: Press briefing and reporter Q&A on policy recommendations designed to encourage innovation and job creation in Ohio on the impact of the device tax on job growth.
WHO: U.S. Rep. Patrick J. Tiberi (12th-OH) U.S. Rep. Jim Renacci (16th-OH) Walter M. Rosebrough, President and CEO, STERIS Mike Lynch, Executive Vice President, Cardinal Health Tony Dennis, CEO, BioOhio Steve Ubl, President and CEO, AdvaMed WHEN: Monday, May 14, 2012, at 12 P.M. EDT WHERE: TechColumbus 1275 Kinnear Road Columbus, Ohio 43212 MEDIA: Please indicate your intention to cover by contacting: Matt Schutte, (614) 675-3686, ext. 6, email@example.com Contact: Wanda Moebius, AdvaMed, (202) 434-7240, firstname.lastname@example.org Matt Schutte, BioOhio, (614) 675-3686, ext. 6, email@example.com /PRNewswire-USNewswire -- May 7, 2012/ SOURCE AdvaMed and BioOhio -0- 05/07/2012 CO: AdvaMed and BioOhio ST: Ohio IN: HEA MTC MEQ SU: MAV STP PRN -- DC02137 -- 0000 05/07/2012 16:16:44 EDT http://www.prnewswire.c